FBLG
FBLG
NASDAQ · Biotechnology

Fibrobiologics Inc

$0.25
+0.02 (+10.83%)
As of Feb 8, 2:26 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 4.23M 4.47M 3.50M
Net Income -124,680 -125,666 -103,892
EPS
Profit Margin -3.0% -2.8% -3.0%
Rev Growth +15.0% +2.0% +12.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 9.10M 8.99M 8.05M
Total Equity 8.67M 8.06M 7.41M
D/E Ratio 1.05 1.12 1.09
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -157,557 -149,483 -127,277
Free Cash Flow -89,797 -95,523 -91,369